Novo Nordisk CEO defends high price off Ozempic and Wegovy

NBC News' Meagan Fitzgerald sits down with Novo Nordisk CEO Lars Jorgenson in Denmark to discuss the high costs and limited supply of the company's popular weight loss drugs, Ozempic and Wegovy.